Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples

Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples

US Patent 5892000 · Granted Apr 6, 1999

Estimated economic value: $519,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Albumin fusion proteins2018
Modified vasoactive intestinal peptides2017
Modified vasoactive intestinal peptides2015
Albumin Fusion Proteins2015
Fusion protein of an exendin to modified transferrin2012
Oral delivery of modified transferrin fusion proteins2012
Fusion protein of exendin-4 to a transferrin (Tf) polypeptide2011
Albumin fusion proteins2010
Albumin fusion proteins2009
Albumin fusion proteins2009
Monoclonal antibody specific for advanced glycosylation endproducts in biologica2006
Monoclonal antibody specific for advanced glycosylation endproducts in biologica2006